SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001636050-20-000105
Filing Date
2020-11-25
Accepted
2020-11-25 21:07:03
Documents
2
Period of Report
2020-11-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160635640441285.html 4  
1 FORM 4 wf-form4_160635640441285.xml 4 3760
2 POA DOCUMENT PANDE ATUL poadocumentpandeatul.htm EX-24 4131
  Complete submission text file 0001636050-20-000105.txt   9551
Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Pande Atul (Reporting) CIK: 0001643071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 201352586